Artwork

Content provided by Investors' Chronicle. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Investors' Chronicle or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Bull vs Bear: Fevertree

21:07
 
Share
 

Manage episode 229170226 series 124416
Content provided by Investors' Chronicle. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Investors' Chronicle or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Fevertree Drinks (FEVR) has become a darling stock for Aim investors, having risen over 1500 per cent since its initial public offering in 2014. Revenues grew to match the share price and now investors wait with anticipation as the company tries to break into the lucrative US market hoping punters pick up its premium-priced tonics and mixers. But, has the share price grown too far? Are there risks with its attempts to break into the competitive US market? Or is the current share price either accurate or even at a discount compared to the potential revenue growth on offer?

Listen to Investors Chronicle specialist writer Julia Faurschou and fund manager of the Merian UK Mid Cap Fund (GB00B1XG9482) Richard Watts fight it out in the latest Bull vs Bear podcast.



Hosted on Acast. See acast.com/privacy for more information.

  continue reading

1028 episodes

Artwork

Bull vs Bear: Fevertree

Investors' Chronicle

316 subscribers

published

iconShare
 
Manage episode 229170226 series 124416
Content provided by Investors' Chronicle. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Investors' Chronicle or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Fevertree Drinks (FEVR) has become a darling stock for Aim investors, having risen over 1500 per cent since its initial public offering in 2014. Revenues grew to match the share price and now investors wait with anticipation as the company tries to break into the lucrative US market hoping punters pick up its premium-priced tonics and mixers. But, has the share price grown too far? Are there risks with its attempts to break into the competitive US market? Or is the current share price either accurate or even at a discount compared to the potential revenue growth on offer?

Listen to Investors Chronicle specialist writer Julia Faurschou and fund manager of the Merian UK Mid Cap Fund (GB00B1XG9482) Richard Watts fight it out in the latest Bull vs Bear podcast.



Hosted on Acast. See acast.com/privacy for more information.

  continue reading

1028 episodes

Alle Folgen

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide